THE FUTURE BELONGS TO BIOTECH FOUNDERS

ABOUT US

TEAM

BLOG

OUR COMMUNITY

GET IN TOUCH

ACCELERATION

LongeVC is an international venture capital firm investing in visionary biotech companies and founders. Focusing on seed and early-stage investment, our mission is to bring to market breakthrough biotech that will change lives and transform the nature of our health.

Our portfolio companies are deploying AI to find new treatments for chronic illnesses, developing SaaS tools to accelerate life-changing medical research and more.
Join the fund using the Get in Touch buttons below.

ABOUT US

The LongeVC team and Advisory Board thoroughly vet all investments to guarantee impact, growth potential and success.

Our portfolio companies have:

Lean operational structure

Rapid scaling plan to reach seed stage

Publications
in peer-reviewed journals

Experienced and ambitious talent

Proof
of concept

OUR TEAM

Managing Partner

Garri Zmudze

Managing Partner

Ilya Suharenko

Managing Partner

Sergey Jakimov

Head of Advisory Board

Alex Zhavoronkov

Read Bio

First industrial validation and partnership commitments

We are curating an ecosystem of biotech and longevity-focused companies ready to change the world. When we invest in a company, we connect them with a network of experienced visionaries and opportunities ready to make progress.

OUR COMMUNITY

Artificial Intelligence for Drug Discovery and Aging Research.

Unlocking the power of life data without borders. Providing the industry with tools for prospective research and R&D acceleration.

Different breeds. Different needs. Every cat is unique. Get to know your cat better with a Cat DNA Test.

A SaaS solution integrating multiple deep biomarkers of aging dubbed 'deep aging clocks' to provide a universal multifactorial measure of human biological age.

Creating mRNA medicines specially formulated to instruct specific cells in the body to fight disease or repair damaged tissue.

Developing the first accurate early stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers.

Bringing together innovators and investors to commercialise the companies that will form the Longevity economy.

Creating a groundbreaking personalized oncology platform that uses tumor twins and AI-supported testing for more effective cancer treatment plans.

ACCELERATION

Our two-track acceleration program supports founders and pre-seed startups in their earliest stages by providing access to capital, expert advising and curated relationship-building with key industry stakeholders.

We believe that successful teams can be created from the ground up as industry trends emerge around them.